In contrast, the CD56bright subset expresses very little or no CD16 (CD56bright CD16low), produces type I pro-inflammatory cytokines IFN gamma and tumor necrosis factor (TNF) alpha [36, 37], and has proangiogenic functions in non-small cell lung cancer patients [38, 39]. The gene discussed is IFNG; the disease is non-small cell lung carcinoma.